Breaking News
Get 45% Off 0
💰 With a 129% YTD gain in the bag, these are our AI’s top global picks for March
Read now

ETF Analysis & Opinion

Contribute
Candy Matheson
Is S&P 500 Showing Warning Gaps? By Candy Matheson - Aug 30, 2019 20

As Friday's trading action came to a close ahead of Monday's Labor Day holiday, an interesting observation to note is this daily chart of the SPX.Since the beginning of August, gaps on the open in...

Stephen McBride
The Reason Stocks Will Soar In The Next 20 Months By Stephen McBride - Aug 30, 2019

A reader asked me last week if it’s time to head for the exits.There’s a lot of fear in the markets right now. Folks are nervous. Maybe you’re nervous. The past two weeks have been...

Matt Simpson
August Has Been Volatile Month: Are We Back To Melt-Up? By Matt Simpson - Aug 30, 2019

August is traditionally a volatile month in the stock markets – and this one is no exception. Already we have seen five large waves of 1,000 pips in the Dow up and down this month. As I noted...

Chris Vermeulen
Energy Sector Sets Up For Another Big Trade By Chris Vermeulen - Aug 29, 2019 2

Our research team has been nailing some really great trades recently in gold, silver, crude oil, ETFs and many other market segments. Some of these trades have resulted in gains of +10% to +20%. One...

Al Brooks
Emini Bad Stop Entry Setups In Tight Trading Range By Al Brooks - Aug 29, 2019

Emini And Forex Trading UpdatePre-Open Market AnalysisThe Emini triggered a minor sell signal yesterday by trading below Tuesday’s low. But, I said that it was a weak sell setup since it was a...

Guy S. Ortmann, CMT
Index Intermediate Trends Remain Split By Guy S. Ortmann, CMT - Aug 29, 2019

Data Remains Largely NeutralAll of the major equity indexes closed higher Wednesday with positive internals as trading volumes declined from the previous down session. No resistance levels were...

Edison
CASI Pharmaceuticals: Evomela Launch Underway By Edison - Aug 29, 2019

CASI Pharmaceuticals Inc (NASDAQ:CASI) has announced that it launched Evomela China, making it officially a commercial stage company. The product for multiple myeloma was approved in China...

Continue with Apple
Continue with Google
or
Sign up with Email